134 related articles for article (PubMed ID: 12778770)
21. Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma.
Tang JW; Rohwäder E; Chu IM; Tsang RK; Steinhagen K; Yeung AC; To KF; Chan PK
J Clin Virol; 2007 Dec; 40(4):284-8. PubMed ID: 17977062
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842
[TBL] [Abstract][Full Text] [Related]
23. [Correlation of heat shock protein 70 expression in nasopharyngeal carcinoma to immunoglobin A against viral capsid antigen of Epstein-Barr virus in sera and its clinical significance].
Chen K; Wang HQ; Zhang Z; Lu XZ; Ouyang D
Ai Zheng; 2008 Jun; 27(6):650-3. PubMed ID: 18570743
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland.
Friborg J; Jarrett RF; Liu MY; Falk KI; Koch A; Olsen OR; Duncan P; Wohlfarht J; Chen JY; Melbye M
J Med Virol; 2007 Dec; 79(12):1877-81. PubMed ID: 17935169
[TBL] [Abstract][Full Text] [Related]
25. A retrospective cohort study of nasopharyngeal adenocarcinoma: a rare histological type of nasopharyngeal cancer.
Guo ZM; Liu WW; He JH
Clin Otolaryngol; 2009 Aug; 34(4):322-7. PubMed ID: 19673979
[TBL] [Abstract][Full Text] [Related]
26. [Carcinoma of the nasopharynx: remarks on its etiology, diagnosis and prognosis].
Ganzer U
Strahlenther Onkol; 1987 Aug; 163(8):519-24. PubMed ID: 3307002
[TBL] [Abstract][Full Text] [Related]
27. Detection of Epstein-Barr virus IgA/EA antibody for diagnosis of nasopharyngeal carcinoma by immunoautoradiography.
Zeng J; Gong CH; Jan MG; Fun Z; Zhang LG; Li HY
Int J Cancer; 1983 May; 31(5):599-601. PubMed ID: 6303967
[TBL] [Abstract][Full Text] [Related]
28. [The usefulness of serum antibody to Epstein-Barr virus-specific DNAase (EDAb) in early detection of nasopharyngeal carcinoma].
Huang D
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):289-91. PubMed ID: 8174467
[TBL] [Abstract][Full Text] [Related]
29. [Improve on serological diagnosis method of nasopharyngeal carcinoma].
Zhan SB; Zhong JM; Mai ZP; Ye SQ; Zhou L; Zeng Y; Liao J
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):65-7. PubMed ID: 19799023
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
[TBL] [Abstract][Full Text] [Related]
31. Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Zangwu County, China.
Zeng Y; Zhong JM; Li LY; Wang PZ; Tang H; Ma YR; Zhu JS; Pan WJ; Liu YX; Wei ZN
Intervirology; 1983; 20(4):190-4. PubMed ID: 6317603
[TBL] [Abstract][Full Text] [Related]
32. Immune responses to Epstein-Barr virus lytic proteins in patients with nasopharyngeal carcinoma.
Liu MY; Huang YT; Sheen TS; Chen JY; Tsai CH
J Med Virol; 2004 Aug; 73(4):574-82. PubMed ID: 15221902
[TBL] [Abstract][Full Text] [Related]
33. Nasopharyngeal carcinoma and Epstein-Barr virus. III. The detection of anti-nuclear antibodies.
Lynn TC; Hsu MM; Hsieh T; Tu SM; Hamajima K
Jpn J Exp Med; 1976 Oct; 46(5):289-95. PubMed ID: 189106
[TBL] [Abstract][Full Text] [Related]
34. [Nasopharyngeal carcinoma (NPC) mortality rate in two districts of Guangdong Province and their relation to IgA antibody level against EB virus capsid antigen].
Zong YS
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):103-5. PubMed ID: 1319889
[TBL] [Abstract][Full Text] [Related]
35. IgA/VCA as a follow-up marker in the monitoring of nasopharyngeal carcinoma.
Sam CK; Abu-Samah AJ; Prasad U
Eur J Surg Oncol; 1994 Oct; 20(5):561-4. PubMed ID: 7926060
[TBL] [Abstract][Full Text] [Related]
36. [Immunohistochemical and cytochemical analysis of lymphocytes and plasma cells in nasopharyngeal carcinoma].
Huang PS; Shen YY
Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):187-9. PubMed ID: 3017661
[TBL] [Abstract][Full Text] [Related]
37. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
[TBL] [Abstract][Full Text] [Related]
39. [Early diagnosis of nasopharyngeal carcinoma using recombinant antigens expressed in bacteria].
Wan Z; Pi G; Sun N
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):74-6. PubMed ID: 12515179
[TBL] [Abstract][Full Text] [Related]
40. Early nasopharyngeal carcinoma among IgA/VCA antibody positive individuals detected by anticomplement immunoenzymatic method.
Zeng Y; Shen SJ; Deng H; Ma JL; Zhang Q; Zhu JS; Cheng JR
Chin Med J (Engl); 1984 Mar; 97(3):155-7. PubMed ID: 6088182
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
